The board of optometry and pharmacy quality assurance commission will use a joint process to determine changes to the oral drug list that includes a means to resolve disagreements.
- (1) Categories of medications approved by the Food and Drug Administration may be added to WAC 246-851-580(1) by rule through consultation and approval of the board of optometry and pharmacy quality assurance commission.
- (2) Medications approved by the Food and Drug Administration in categories that are within the scope of optometric physician practice that are not included in WAC 246-851-580(1) may be added through consultation and approval of the board of optometry and the pharmacy quality assurance commission. Approval will follow the joint process established by the board and commission.
- (3) WAC 246-851-580 and 246-851-590 may be updated to reflect additions or removal of medications.
[Statutory Authority: RCW 18.54.070(2). WSR 14-12-059, § 246-851-610, filed 5/30/14, effective 6/30/14. Statutory Authority: 2003 c 142 and RCW 18.54.070(2). WSR 04-12-127, § 246-851-610, filed 6/2/04, effective 7/3/04.]